Rankings
▼
Calendar
AXSM FY 2020 Earnings — Axsome Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
AXSM
Axsome Therapeutics, Inc.
$9B
FY 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$99M
Net Income
-$103M
EPS (Diluted)
$-2.83
Cash Flow
Operating Cash Flow
-$78M
Free Cash Flow
-$79M
Stock-Based Comp.
$15M
Balance Sheet
Total Assets
$186M
Total Liabilities
$72M
Stockholders' Equity
$114M
Cash & Equivalents
$184M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
-$37,330
+100.0%
Operating Income
-$99M
-$67M
-47.4%
Net Income
-$103M
-$68M
-50.6%
← Q4 2019
All Quarters
Q1 2020 →